Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of Tengjun Biotechnology Corp. from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Tengjun Biotechnology Corp. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q4 2010 to Q2 2023.
  • Tengjun Biotechnology Corp. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Jun 2023 was $15,264,970, a 654% increase year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

Tengjun Biotechnology Corp. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $15,264,970 +$13,240,024 +654% 30 Jun 2023 10-Q 15 Aug 2023 2023 Q2
Q1 2023 $15,768,423 +$17,830,784 31 Mar 2023 10-Q 15 Aug 2023 2023 Q2
Q4 2022 $14,972,537 +$17,258,267 31 Dec 2022 10-Q 15 Aug 2023 2023 Q2
Q3 2022 $7,993,473 +$9,684,042 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $2,024,946 +$3,604,537 30 Jun 2022 10-Q 15 Aug 2023 2023 Q2
Q1 2022 $-2,062,361 -$724,744 -54% 31 Mar 2022 10-Q 15 Aug 2023 2023 Q2
Q4 2021 $-2,285,730 -$1,107,615 -94% 31 Dec 2021 10-Q 15 Aug 2023 2023 Q2
Q3 2021 $-1,690,569 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $-1,579,591 30 Jun 2021 10-Q 14 Nov 2022 2022 Q3
Q1 2021 $-1,337,617 31 Mar 2021 10-Q 14 Nov 2022 2022 Q3
Q4 2020 $-1,178,115 -$759,087 -181% 31 Dec 2020 10-K 17 Apr 2023 2022 FY
Q4 2019 $-419,028 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q1 2012 $-31,101 31 Mar 2012 10-Q 19 Apr 2012 2012 Q1
Q4 2011 $-25,462 -$1,470 -6.1% 31 Dec 2011 10-Q 19 Apr 2012 2012 Q1
Q3 2011 $-24,796 30 Sep 2011 10-Q 19 Oct 2011 2011 Q3
Q4 2010 $-23,992 31 Dec 2010 10-Q 19 Apr 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.